TrialCancer immunology, immunotherapy : CII2012

Analysis of pre-treatment markers predictive of treatment benefit for the therapeutic cancer vaccine MVA-5T4 (TroVax).

Richard Harrop et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.